PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

The Quest for Meaningful Pharma–Patient Dialogue

Executive Roundtable: Where is Your Physician?

Beyond KOL Marketing: Tapping Digital Opinion Influencers

Top Story
Biosimilars Overcome Hurdles, Move into Mainstream
The FDA ruling that exempts biosimilar makers from waiting an extra six months after approval to distribute a new product should help overcome delays in future biosimilar sales, writes Jill Wechsler
/Read more/
Advertisement
The Changing Market for Drugs to Treat Orphan Diseases
Live Webinar: Tuesday, July 18 at 10am EDT
Register now
Digital Communications
Decoding the Disruption: Making Meaningful Marketing Out of Top Trends
Separating the meaningful from the merely novel, Bill Drummy outlines his Top Ten digital marketing trends for 2017
/Read more/
Advertisement
Unlocking the Patient Voice: How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs
Live Webcast: Wednesday, July 12 at 10:00am EDT
Register now
Europe
EU Countries Square Up to Drug Firms on Prices
Last month's EFPIA and EU Health Council annual conferences highlighted the growing divisions—and resentments—between industry and governments on drug pricing. Reflector reports
/Read more/
Advertisement
Through the Patient's Eyes - Needs, Behaviors and the Science Behind it All
On Demand
Learn more
Comment
Could Valeant Pharmaceuticals Have Gifted Teva its "Biggest Commercial Hope"?
Intellectual property analysis of one recently approved drug shows how Valeant might have missed out on at least one vital acquisition opportunity. Duncan Clark reports
/Read more/
Advertisement
Emerging Biopharma and Rare Disease: Finding a Needle in a Haystack
On Demand
Learn more
Special Feature
Pharm Exec's Top 50 Pharma Companies 2017
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead
/Read more/
Advertisement
Using Outbound Virtual Engagement Strategies to Break Through Co-Pay Savings Program Plateaus
Sponsored by TrialCard
Download Whitepaper
Calendar
/ August 8–9: Bio/Pharma Strategic Portfolio Management Summit /
Cambridge, MA
/ August 14–16: 11th Annual Forum on Transparency & Aggregate Spend /
Washington, DC
/ August 15–16: Reimbursement and Access /
Philadelphia, PA
/ August 22–23: Bio/Pharma Forum on Data Science /
Philadelphia, PA
/ September 14-15, 2017: Compliance Congress for Specialty Products /
Boston, MA
/ September 14–15: Risk Based Global Monitoring 2017 /
Barcelona, Spain
/ October 24–25: 12th Annual Value-Based Oncology Management /
Scottsdale, AZ
/ December 12–13: Patient Journey Mapping: From Diagnosis to Treatment Philadelphia, PA /
Philadelphia, PA
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
Advertisement
Coming to terms with Patient Centricity
On Demand
Learn more
Advertisement
Launch Excellence V: Surviving and thriving in a specialized world
On Demand
Learn more
Industry update
//Astellas announced two senior-level promotions in its Marketing Strategy and US Commercial organizations. Caroline Walkinshaw has been promoted to Executive Director, Market Intelligence and Analytics, Marketing Strategy. Jacquelyn Bonnell has been promoted to national Vice President, Oncology Sales for the US Commercial organization. //Sarepta Therapeutics (Cambridge, MA) named Douglas Ingram as its new President and CEO. He will also serve on the company's Board of Directors. //Huron announced that life sciences and strategy thought leader John Westwood has joined the company as Managing Director and Global Head of Huron's life sciences practice.//
Advertisement
Talking the Patients' Language – the importance of effective, patient-centered engagement
On Demand
Learn more
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com